Literature DB >> 20116418

DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery.

Yang Zhang1, Huimei Li, Jing Sun, Jie Gao, Wei Liu, Bohua Li, Yajun Guo, Jianming Chen.   

Abstract

Cationic liposomes (CLs) composed of 3beta-[N-(N',N'-dimethylaminoethane) carbamoyl] cholesterol (DC-Chol) and dioleoylphosphatidylethanolamine (DOPE) (DC-Chol/DOPE liposomes) have been classified as one of the most efficient gene delivery systems. Our study aims to examine the effect of the molar ratio of DC-Chol/DOPE, PEGylation and serum on the pDNA (plasmid pDNA) and siRNA (small interfering RNA) transfection of DC-Chol/DOPE liposomes. The results showed that the most efficient DC-Chol/DOPE liposomes for pDNA or siRNA delivery were at a 1:2 or 1:1 molar ratio of DC-Chol/DOPE, respectively. The transfection efficiency of DC-Chol/DOPE liposomes increased along with increased weight ratio of DC-Chol/siRNA. However, the pDNA transfection efficiency decreased along with increased weight ratio of DC-Chol/pDNA from 3/1. As expected, PEGylation decreased siRNA and pDNA transfection efficiency of DC-Chol/DOPE liposomes. In PEGylated DC-Chol/DOPE liposomes, increased weight ratio of DC-Chol/pDNA from 3/1 did not lead to higher pDNA transfection efficiency, whereas increased weight ratio of DC-Chol/siRNA resulted in increased siRNA transfection efficiency. Furthermore, the serum did not significantly inhibit the pDNA and siRNA transfection efficiency of DC-Chol/DOPE liposomes. In conclusion, our results elucidated the influence factors of DC-Chol/DOPE liposome transfection and would reveal that siRNA and pDNA transfection mechanisms were different in DC-Chol/DOPE liposomes. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116418     DOI: 10.1016/j.ijpharm.2010.01.035

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  37 in total

1.  SPANosomes as delivery vehicles for small interfering RNA (siRNA).

Authors:  Chenguang Zhou; Yicheng Mao; Yasuro Sugimoto; Yue Zhang; Naveen Kanthamneni; Bo Yu; Robert W Brueggemeier; L James Lee; Robert J Lee
Journal:  Mol Pharm       Date:  2011-12-29       Impact factor: 4.939

Review 2.  Effect of surface properties on liposomal siRNA delivery.

Authors:  Yuqiong Xia; Jie Tian; Xiaoyuan Chen
Journal:  Biomaterials       Date:  2015-12-02       Impact factor: 12.479

Review 3.  Delivery of intracellular-acting biologics in pro-apoptotic therapies.

Authors:  Hongmei Li; Chris E Nelson; Brian C Evans; Craig L Duvall
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 4.  Progress of cationic gene delivery reagents for non-viral vector.

Authors:  Kai Ma; Chun-Liu Mi; Xiang-Xiang Cao; Tian-Yun Wang
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

5.  Novel lipoidal amine-based nanocarrier formulations for siRNA delivery.

Authors:  Chenguang Zhou; Zhang Yue; L James Lee; Robert J Lee
Journal:  Ther Deliv       Date:  2012-06

6.  Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.

Authors:  Li Gu; Leora M Nusblat; Nasim Tishbi; Sarah C Noble; Chaya M Pinson; Evan Mintzer; Charles M Roth; Kathryn E Uhrich
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 9.776

Review 7.  Non-viral nanocarriers for siRNA delivery in breast cancer.

Authors:  Jing Zhang; Xiang Li; Leaf Huang
Journal:  J Control Release       Date:  2014-05-27       Impact factor: 9.776

8.  Manganese-loaded lipid-micellar theranostics for simultaneous drug and gene delivery to lungs.

Authors:  M Howell; J Mallela; C Wang; S Ravi; S Dixit; U Garapati; S Mohapatra
Journal:  J Control Release       Date:  2013-02-06       Impact factor: 9.776

9.  Dual-function theranostic nanoparticles for drug delivery and medical imaging contrast: perspectives and challenges for use in lung diseases.

Authors:  M Howell; C Wang; A Mahmoud; G Hellermann; S S Mohapatra; S Mohapatra
Journal:  Drug Deliv Transl Res       Date:  2013-08-01       Impact factor: 4.617

Review 10.  Novel delivery approaches for cancer therapeutics.

Authors:  Ashim K Mitra; Vibhuti Agrahari; Abhirup Mandal; Kishore Cholkar; Chandramouli Natarajan; Sujay Shah; Mary Joseph; Hoang M Trinh; Ravi Vaishya; Xiaoyan Yang; Yi Hao; Varun Khurana; Dhananjay Pal
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.